New York City Chapter president and CEO Lou-Ellen Barkan (middle) and Alzheimer Champion David Hyde Pierce (left) helped ring the New York Stock Exchange opening bell Monday morning.

Seven years ago, Ken Rabb was a legal aid lawyer and a weekend painter. But at the age of 53, he was diagnosed with young onset Alzheimer's. Soon he was on disability and unable to work. Although he talks relatively little now and can no longer read, his art has flourished and he spends much of his time painting.

The U.S. Constitution (Article I, Section 2) mandates a headcount of everyone residing in the United States. The population totals determine each state’s Congressional representation. The numbers also affect funding in your community and help inform decision makers about how your community is changing.

Millions of people who use non-steroidal anti-inflammatory drugs (NSAIDs), such as naproxen and ibuprofen, shouldn't bank on the drugs helping them ward off dementia.

Scientists are creating tests to show when it's time for people with early Alzheimer's disease to stop driving. It's one of a family's most wrenching decisions, and as Alzheimer's increasingly is diagnosed in its earliest stages, it can be hard to tell when a loved one is poised to become a danger.

Hit hard by the economic downturn? Looking for relief from paying the full cost of your prescription drugs? New York State announces the New York Prescription Saver, a free prescription discount card that will help save on the cost of prescription drugs. The card is for New York State residents who are 50 to 64 years old, or persons with a disability regardless of age. Income eligibility limits are up to $35,000 single and $50,000 married. Those with Medicaid coverage are not eligible.

As many as 5.3 million people in the United States are living with Alzheimer’s. Alzheimer's and dementia triple healthcare costs for Americans age 65 and older. Every 70 seconds, someone develops Alzheimer’s. Alzheimer's is the sixth-leading cause of death. The direct and indirect costs of Alzheimer's and other dementias to Medicare, Medicaid and businesses amount to more than $148 billion each year. These are just a few of the facts in the new report. View the full report here.